Pulmologix's Series B Round

Pulmologix raised a round of funding on September 22, 2014.

Pulmologix is a Sweden-based pharma company. The company's lead compound is a new Oral Non-Steroidal Anti-asthmatic (ONSA) for the treatment of early onset allergic asthma. It is scheduled to enter ph…

Articles about Pulmologix's Series B Round: